Clinical Trial Update: A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the effects of fesoterodine and oxybutynin on cognitive function in individuals with mild cognitive impairment and overactive bladde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Overactive Bladder

Drugs mentioned

• Fesoterodine (fesoterodine)
• oxybutynin (oxybutynin)

Snippet

Sponsor: University of Alberta | Conditions: Overactive Bladder, Mild Cognitive Impairment | Phase 2 | Status: COMPLETED